TB vaccines in clinical development

TB vaccines in clinical development

Показать другие версии (2)

The 4th Global Forum on TB Vaccines, convened in Shanghai, China, from 21 - 24 April 2015, brought together a wide and diverse community involved in tuberculosis vaccine research and development to discuss the current status of, and future directions for this critical effort. This paper summarizes t...

Полное описание

Библиографические подробности
Главные авторы:	Ginsberg, A, Ruhwald, M, Mearns, H, Mcshane, H
Формат:	Journal article
Опубликовано:	Elsevier 2016

Схожие документы

TB vaccines in clinical development
по: Ginsberg, AM, и др.
Опубликовано: (2016)

TB vaccines in clinical development
по: Ginsburg, A, и др.
Опубликовано: (2016)

TB vaccine development: where are we and why is it so difficult?
по: Wilkie, M, и др.
Опубликовано: (2014)

A review of clinical models for the evaluation of human TB vaccines.
по: O'Shea, M, и др.
Опубликовано: (2016)

Progress and challenges in TB vaccine development
по: Voss, G, и др.
Опубликовано: (2018)

Towards new TB vaccines
по: Brazier, B, и др.
Опубликовано: (2020)

Need for more TB vaccine field sites.
по: Mcshane, H
Опубликовано: (2009)

DEVELOPING A NEW TB VACCINE: BOOSTING BCG WITH MVA85A
по: Mcshane, H
Опубликовано: (2008)

Preclinical development of an in vivo BCG challenge model for testing candidate TB vaccine efficacy.
по: Minassian, A, и др.
Опубликовано: (2011)

New TB vaccine granted orphan drug status.
по: Lang, T, и др.
Опубликовано: (2005)

A mycobacterial growth inhibition assay (MGIA) for bovine TB vaccine development
по: Pepponi, I, и др.
Опубликовано: (2017)

Co-infection with HIV and TB: double trouble.
по: Mcshane, H
Опубликовано: (2005)

Progress and challenges in TB vaccine development [version 1; referees: 2 approved]
по: Gerald Voss, и др.
Опубликовано: (2018-02-01)

A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy data.
по: McShane, H, и др.
Опубликовано: (2014)

A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy data
по: McShane, H, и др.
Опубликовано: (2014)

Evaluating aerosol administration of a candidate TB vaccine MVA85A
по: Thomas, Z, и др.
Опубликовано: (2014)

Preclinical development of an in vivo BCG challenge model for testing candidate TB vaccine efficacy.
по: Angela M Minassian, и др.
Опубликовано: (2011-01-01)

Identification and evaluation of novel protective antigens for the development of a candidate TB subunit vaccine
по: Stylianou, E, и др.
Опубликовано: (2018)

Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults.
по: Pathan, A, и др.
Опубликовано: (2012)

Phase I/II clinical trial of MVA85A in individuals with latent tuberculosis: The first subunit TB vaccine in clinical trial
по: Sander, C, и др.
Опубликовано: (2005)

A new TB vaccine, MVA85A, induces durable antigen-specific responses 14 months after vaccination in African infants
по: Odutola, A, и др.
Опубликовано: (2012)

A new TB vaccine, MVA85A, induces durable antigen-specific responses 14 months after vaccination in African infants.
по: Odutola, A, и др.
Опубликовано: (2012)

Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults
по: Pathan, A, и др.
Опубликовано: (2012)

Designing an adaptive phase II/III trial to evaluate efficacy, safety and immune correlates of new TB vaccines in young adults and adolescents
по: Rustomjee, R, и др.
Опубликовано: (2013)

The candidate TB vaccine, MVA85A, induces highly durable Th1 responses.
по: Tameris, M, и др.
Опубликовано: (2014)

Designing an adaptive phase II/III trial to evaluate efficacy, safety and immune correlates of new TB vaccines in young adults and adolescents.
по: Rustomjee, R, и др.
Опубликовано: (2013)

Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85A.
по: Whelan, K, и др.
Опубликовано: (2009)

The candidate TB vaccine, MVA85A, induces highly durable Th1 responses
по: Tameris, M, и др.
Опубликовано: (2014)

Clinical Development of New TB Vaccines: Recent Advances and Next Steps
по: Mark Hatherill, и др.
Опубликовано: (2020-01-01)

Differential cytokine levels in adults induced by a Novel candidate TB boost vaccine, MVA85A-according to previous BCG vaccination status
по: Owiafe, P, и др.
Опубликовано: (2012)

Using an effective TB vaccination regimen to identify immune responses associated with protection in the murine model
по: Pinpathomrat, N, и др.
Опубликовано: (2021)

Tuberculosis vaccines in clinical trials.
по: Rowland, R, и др.
Опубликовано: (2011)

Developing an improved vaccine against tuberculosis.
по: Mcshane, H
Опубликовано: (2004)

Bayesian Augmented Clinical Trials in TB Therapeutic Vaccination
по: Dimitrios Kiagias, и др.
Опубликовано: (2021-10-01)

Experimental animal modelling for TB vaccine development
по: Pere-Joan Cardona, и др.
Опубликовано: (2017-03-01)

Comparison of the safety and immunogenicity of a candidate TB vaccine, MVA85A, given by the intramuscular or intradermal route in BCG-vaccinated adults
по: Harris, S, и др.
Опубликовано: (2011)

Insights and challenges in tuberculosis vaccine development
по: McShane, H
Опубликовано: (2019)

Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery.
по: Meyer, J, и др.
Опубликовано: (2013)

Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery
по: Meyer, J, и др.
Опубликовано: (2013)

Phase I trial evaluating the safety and immunogenicity of candidate TB vaccine MVA85A, delivered by aerosol to healthy M.tb-infected adults
по: Riste, M, и др.
Опубликовано: (2021)